SEPN
Septerna Inc$40.88-1.72 (-4.04%)Prev Close$42.60·MCap$2.44B·P/E—·Vol262.3K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
17
$46.49M
◆
Net Activity
Net Seller
$46.49M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Septerna Inc (SEPN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 17 insider sales totaling $46.49M. The most recent insider transaction was by Ezekowitz Alan (director), who sold $3.93M worth of shares on Nov 13, 2026. Septerna Inc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.44B.
SEPN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Ezekowitz Alan | director | Sell | 81,820 | $48.09 | $3.93M | 110,481-43% |
| Oct 19, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 4,000 | $37.41 | $149.6K | 177,115 |
| Sep 3, 2026 | Long Daniel D. | officer: SVP, Drug Discovery | Sell | 3,333 | $37.83 | $126.1K | 96,412 |
| Aug 14, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Sell | 746,500 | $42.50 | $31.73M1.7% OS | 725,443-51% |
| Aug 14, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 147,200 | $50.27 | $7.40M | 6,068,532 |
| Aug 13, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 25,000 | $44.00 | $1.10M | 174,209 |
| Aug 5, 2026 | Long Daniel D. | officer: SVP, Drug Discovery | Sell | 3,334 | $34.47 | $114.9K | 98,746 |
| Jul 17, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 4,000 | $33.99 | $136.0K | 174,209 |
| Jul 2, 2026 | Long Daniel D. | officer: SVP, Drug Discovery | Sell | 3,333 | $34.36 | $114.5K | 97,645 |
| Jun 30, 2026 | Shaikhly Samira | officer: Chief People Officer | Sell | 2,178 | $35.18 | $76.6K | 793-73% |
| Jun 24, 2026 | Long Daniel D. | officer: SVP, Drug Discovery | Sell | 15,000 | $35.51 | $532.6K | 103,412 |
| Jun 16, 2026 | Shaikhly Samira | officer: Chief People Officer | Sell | 6,250 | $35.08 | $219.2K | 793-89% |
| Jun 3, 2026 | Shaikhly Samira | officer: Chief People Officer | Sell | 5,935 | $28.93 | $171.7K | 5,028-54% |
| May 28, 2026 | Shaikhly Samira | officer: Chief People Officer | Sell | 11,798 | $30.06 | $354.7K | 793-94% |
| Apr 17, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 4,000 | $24.34 | $97.3K | 175,636 |
| Feb 20, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 4,000 | $28.97 | $115.9K | 176,009 |
| Feb 18, 2026 | Bhatt Elizabeth | President and COO | Sell | 4,000 | $28.97 | $115.9K | 0 |
| Nov 13, 2025 | Long Daniel D. | SVP, Drug Discovery | Sell | 3,501 | $18.06 | $63.2K | 92,911 |
| Mar 10, 2025 | Ezekowitz Alan | Buy | 13,319 | $6.93 | $92.3K | 117,420 | |
| Mar 6, 2025 | Ezekowitz Alan | Buy | 86,681 | $5.95 | $515.9K | 104,101+498% | |
| Feb 27, 2025 | Finer Jeffrey | CEO and President | Buy | 17,000 | $5.70 | $97.0K | 771,907 |
| Feb 27, 2025 | Labrucherie Gil M | Chief Financial Officer | Buy | 10,000 | $5.69 | $56.9K | 40,000+33% |
| Feb 26, 2025 | Third Rock Ventures VI, L.P. | Buy | 18,861 | $6.00 | $113.1K | 4,211,659 | |
| Feb 24, 2025 | Third Rock Ventures VI, L.P. | Buy | 1,040,342 | $5.93 | $6.17M2.3% OS | 4,192,798+33% | |
| Feb 21, 2025 | Labrucherie Gil M | Chief Financial Officer | Buy | 30,000 | $5.74 | $172.3K | 30,000 |
| Oct 30, 2024 | RA CAPITAL MANAGEMENT, L.P. | Buy | 4,170,000 | $18.00 | $75.06M9.3% OS | 5,523,915+308% | |
| Oct 28, 2024 | Third Rock Ventures V, L.P. | Buy | 650,000 | $18.00 | $11.70M1.4% OS | 6,215,591 |
SEPN Insider Buying Activity
The following table shows recent insider purchases of Septerna Inc (SEPN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Ezekowitz Alan | Buy | 13,319 | $6.93 | $92.3K | 117,420 | |
| Mar 6, 2025 | Ezekowitz Alan | Buy | 86,681 | $5.95 | $515.9K | 104,101+498% | |
| Feb 27, 2025 | Finer Jeffrey | CEO and President | Buy | 17,000 | $5.70 | $97.0K | 771,907 |
| Feb 27, 2025 | Labrucherie Gil M | Chief Financial Officer | Buy | 10,000 | $5.69 | $56.9K | 40,000+33% |
| Feb 26, 2025 | Third Rock Ventures VI, L.P. | Buy | 18,861 | $6.00 | $113.1K | 4,211,659 | |
| Feb 24, 2025 | Third Rock Ventures VI, L.P. | Buy | 1,040,342 | $5.93 | $6.17M2.3% OS | 4,192,798+33% | |
| Feb 21, 2025 | Labrucherie Gil M | Chief Financial Officer | Buy | 30,000 | $5.74 | $172.3K | 30,000 |
| Oct 30, 2024 | RA CAPITAL MANAGEMENT, L.P. | Buy | 4,170,000 | $18.00 | $75.06M9.3% OS | 5,523,915+308% | |
| Oct 28, 2024 | Third Rock Ventures V, L.P. | Buy | 650,000 | $18.00 | $11.70M1.4% OS | 6,215,591 |
SEPN Insider Selling Activity
The following table shows recent insider sales of Septerna Inc (SEPN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Ezekowitz Alan | director | Sell | 81,820 | $48.09 | $3.93M | 110,481-43% |
| Oct 19, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 4,000 | $37.41 | $149.6K | 177,115 |
| Sep 3, 2026 | Long Daniel D. | officer: SVP, Drug Discovery | Sell | 3,333 | $37.83 | $126.1K | 96,412 |
| Aug 14, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Sell | 746,500 | $42.50 | $31.73M1.7% OS | 725,443-51% |
| Aug 14, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 147,200 | $50.27 | $7.40M | 6,068,532 |
| Aug 13, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 25,000 | $44.00 | $1.10M | 174,209 |
| Aug 5, 2026 | Long Daniel D. | officer: SVP, Drug Discovery | Sell | 3,334 | $34.47 | $114.9K | 98,746 |
| Jul 17, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 4,000 | $33.99 | $136.0K | 174,209 |
| Jul 2, 2026 | Long Daniel D. | officer: SVP, Drug Discovery | Sell | 3,333 | $34.36 | $114.5K | 97,645 |
| Jun 30, 2026 | Shaikhly Samira | officer: Chief People Officer | Sell | 2,178 | $35.18 | $76.6K | 793-73% |
| Jun 24, 2026 | Long Daniel D. | officer: SVP, Drug Discovery | Sell | 15,000 | $35.51 | $532.6K | 103,412 |
| Jun 16, 2026 | Shaikhly Samira | officer: Chief People Officer | Sell | 6,250 | $35.08 | $219.2K | 793-89% |
| Jun 3, 2026 | Shaikhly Samira | officer: Chief People Officer | Sell | 5,935 | $28.93 | $171.7K | 5,028-54% |
| May 28, 2026 | Shaikhly Samira | officer: Chief People Officer | Sell | 11,798 | $30.06 | $354.7K | 793-94% |
| Apr 17, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 4,000 | $24.34 | $97.3K | 175,636 |
| Feb 20, 2026 | Bhatt Elizabeth | officer: President and COO | Sell | 4,000 | $28.97 | $115.9K | 176,009 |
| Feb 18, 2026 | Bhatt Elizabeth | President and COO | Sell | 4,000 | $28.97 | $115.9K | 0 |
| Nov 13, 2025 | Long Daniel D. | SVP, Drug Discovery | Sell | 3,501 | $18.06 | $63.2K | 92,911 |
SEPN Insiders
RA CAPITAL MANAGEMENT, L.P.
director, 10 percent owner:
Bought $75.06MSold $31.73M
2 tradesLast: Aug 14, 2026
Similar Stocks to SEPN
VRTX
Vertex Pharmaceuticals Incorporated
$536.14-0.42%
$138.69B
REGN
Regeneron Pharmaceuticals, Inc.
$948.88-0.62%
$99.23B
MRNA
Moderna, Inc.
$214.97-3.55%
$93.61B
RVMD
Revolution Medicines, Inc.
$166.45-3.42%
$39.08B
INSM
Insmed Incorporated
$122.96+1.38%
$26.58B
UTHR
United Therapeutics Corporation
$585.50-0.96%
$25.18B
INCY
Incyte Corporation
$120.12-0.66%
$24.66B
ALNY
Alnylam Pharmaceuticals, Inc.
$159.51-3.31%
$21.41B